According to The Kansas City Star, Cole was a promising young man from Wisconsin who had suffered from chronic asthma since childhood. By taking daily doses of the prophylactic inhaler Advair Diskus, he was able to live a full life despite his handicap.
Cole’s insurance paid for his reasonably priced prescription drugs for many years. When he visited Walgreens in January 2024, he was surprised to discover that his life-saving medication was no longer covered. The new cost is $539.

On January 10, 2024, Cole went to his neighborhood Walgreens as usual to fill his prescription. However, he chose not to pay the customary $66 after discovering that his insurance no longer covered Advair Diskus.
The pharmacist allegedly informed him that no generics or less expensive substitutes were available and neglected to get in touch with his physician or insurance provider to find a solution.
Cole was distraught and upset as he left the drugstore without his prescription. He used an old emergency inhaler to control his breathing over the course of the following two days. Bad things happened five days later. Cole was unable to breathe due to a severe asthma episode. He fainted as his roommate brought him to the medical hospital.
Despite the greatest efforts of the medical staff, Cole never regained consciousness. His parents made the painful decision to take him off life support after six days. The official announcement of Cole’s passing came on January 21, 2024.

Since then, Cole’s irate parents have sued Walgreens and OptumRx, the pharmaceutical plan manager, claiming that they put profits ahead of patients. A Walgreens representative informed HuffPost that they were unable to comment because of ongoing legal proceedings.
According to the lawsuit, OptumRx changed its formulary in 2024 and required a doctor’s prior consent before a patient may use Advair Diskus or a generic version of the drug. However, the lawsuit claims that Cole’s insurer and Walgreens neglected to inform him that his prescription would no longer be reimbursed, which is a blatant disregard for state law.
Michael Trunk, the family’s lawyer, stated unequivocally that “the evidence in this case will demonstrate that Cole’s death was directly caused by OptumRx and Walgreens, who prioritized profits.”
Additionally, the lawsuit claims that OptumRx participated in “non-medical switching,” a practice in which pharmacy benefit managers pressure patients to take more costly drugs in return for manufacturer kickbacks. Only Cole’s two more recent brand-name medications were reportedly covered by OptumRx; the manufacturers of these medications reportedly paid large rebates to obtain advantageous formulary placement.
Outrage and calls for reform have been triggered by Cole’s horrifying account. At a December congressional hearing, Massachusetts Representative Jake Auchincloss paid tribute to Cole and urged lawmakers to enact the Pharmacists Fight Back Act. The proposed law aims to stop pharmaceutical benefit managers from exploiting people over prices and to stop situations like Cole’s from happening again.
The conflict directly affects Cole’s family. They hope his narrative will raise awareness of the terrible effects of a dysfunctional healthcare system and seek justice for their child. Schmidtknecht’s family lawyer told WMTV, “We hope that this lawsuit and Cole’s death will lead them to kind of reflect on their own policies and change their policies going forward.” It is imperative that Cole’s story be heard. To spark discussion and raise awareness of the issues affecting our healthcare system, share this article.






